XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Redeemable Noncontrolling Interest and Stockholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Redeemable Noncontrolling Interest
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2018   $ 41,800        
Increase (Decrease) in Temporary Equity [Roll Forward]            
Adjustment of redeemable noncontrolling interest $ (4,700) 4,700       $ (4,700)
Ending balance at Mar. 31, 2019   46,500        
Beginning balance, shares at Dec. 31, 2018     85,832,454      
Beginning balance at Dec. 31, 2018 483,152   $ 1 $ 764,033 $ (83) (280,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options, shares     146,318      
Issuance of common stock upon exercise of stock options 538     538    
Vesting of common stock exercised early 56     56    
Common stock issued under employee stock purchase plan (in shares)     119,702      
Common stock issued under employee stock purchase plan 1,933     1,933    
Stock-based compensation 3,183     3,183    
Other comprehensive gain (loss), net of tax impact 416       416  
Net loss (21,351)         (21,351)
Ending balance, shares at Mar. 31, 2019     86,098,474      
Ending balance at Mar. 31, 2019 468,134   $ 1 771,009 333 (303,209)
Beginning balance at Dec. 31, 2019   49,600        
Increase (Decrease) in Temporary Equity [Roll Forward]            
Adjustment of redeemable noncontrolling interest 4,100 (4,100)       4,100
Ending balance at Mar. 31, 2020   $ 45,500        
Beginning balance, shares at Dec. 31, 2019     94,261,414      
Beginning balance at Dec. 31, 2019 $ 798,393   $ 1 1,150,090 1,111 (352,809)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options, shares 242,003   242,003      
Issuance of common stock upon exercise of stock options $ 1,504     1,504    
Vesting of restricted stock units (in shares)     5,594      
Vesting of common stock exercised early 13     13    
Stock-based compensation 6,338     6,338    
Other comprehensive gain (loss), net of tax impact 6,594       6,594  
Net loss (31,829)         (31,829)
Ending balance, shares at Mar. 31, 2020     94,509,011      
Ending balance at Mar. 31, 2020 $ 785,113   $ 1 $ 1,157,945 $ 7,705 $ (380,538)